These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17939753)

  • 1. Modification of Kolmogorov-Smirnov test for DNA content data analysis through distribution alignment.
    Huang S; Yeo AA; Li SD
    Assay Drug Dev Technol; 2007 Oct; 5(5):663-71. PubMed ID: 17939753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixture-model classification in DNA content analysis.
    Wang H; Huang S
    Cytometry A; 2007 Sep; 71(9):716-23. PubMed ID: 17654654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parameter-free testing of the shape of a probability distribution.
    Broom M; Nouvellet P; Bacon JP; Waxman D
    Biosystems; 2007; 90(2):509-15. PubMed ID: 17293028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data.
    Mpindi JP; Swapnil P; Dmitrii B; Jani S; Saeed K; Wennerberg K; Aittokallio T; Östling P; Kallioniemi O
    Bioinformatics; 2015 Dec; 31(23):3815-21. PubMed ID: 26254433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Score statistics of global sequence alignment from the energy distribution of a modified directed polymer and directed percolation problem.
    Sardiu ME; Alves G; Yu YK
    Phys Rev E Stat Nonlin Soft Matter Phys; 2005 Dec; 72(6 Pt 1):061917. PubMed ID: 16485984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A software framework enabling analysis of plate-based flow cytometry data for high-throughput screening.
    Stanton RA; Escobar S; Elliott GS
    Assay Drug Dev Technol; 2010 Apr; 8(2):228-37. PubMed ID: 20035617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTS-Corrector: software for the statistical analysis and correction of experimental high-throughput screening data.
    Makarenkov V; Kevorkov D; Zentilli P; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2006 Jun; 22(11):1408-9. PubMed ID: 16595559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistics of assay validation in high throughput cell imaging of nuclear factor kappaB nuclear translocation.
    Morelock MM; Hunter EA; Moran TJ; Heynen S; Laris C; Thieleking M; Akong M; Mikic I; Callaway S; DeLeon RP; Goodacre A; Zacharias D; Price JH
    Assay Drug Dev Technol; 2005 Oct; 3(5):483-99. PubMed ID: 16305306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of two-part models with competitors.
    Lachenbruch PA
    Stat Med; 2001 Apr; 20(8):1215-34. PubMed ID: 11304737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved statistical methods for hit selection in high-throughput screening.
    Brideau C; Gunter B; Pikounis B; Liaw A
    J Biomol Screen; 2003 Dec; 8(6):634-47. PubMed ID: 14711389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the use of historical control data in pre-clinical safety studies.
    Marringwa JT; Faes C; Aerts M; Geys H; Teuns G; Van Den Poel B; Bijnens L
    J Biopharm Stat; 2007; 17(3):493-509. PubMed ID: 17479396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robust statistical methods for hit selection in RNA interference high-throughput screening experiments.
    Zhang XD; Yang XC; Chung N; Gates A; Stec E; Kunapuli P; Holder DJ; Ferrer M; Espeseth AS
    Pharmacogenomics; 2006 Apr; 7(3):299-309. PubMed ID: 16610941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical analysis of systematic errors in high-throughput screening.
    Kevorkov D; Makarenkov V
    J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular HTS assays for pharmacological characterization of Na(V)1.7 modulators.
    Trivedi S; Dekermendjian K; Julien R; Huang J; Lund PE; Krupp J; Kronqvist R; Larsson O; Bostwick R
    Assay Drug Dev Technol; 2008 Apr; 6(2):167-79. PubMed ID: 18078380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-part permutation tests for DNA methylation and microarray data.
    Neuhäuser M; Boes T; Jöckel KH
    BMC Bioinformatics; 2005 Feb; 6():35. PubMed ID: 15725357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the use of the Kolmogorov-Smirnov statistical test for immunofluorescence histogram comparison.
    Lampariello F
    Cytometry; 2000 Mar; 39(3):179-88. PubMed ID: 10685074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.